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BACKGROUND: Treatment of clean–contaminated and contaminated ventral hernia defects remains
controversial. Newer prosthetic materials may play an important role in these patients.
METHODS: Ten patients with Ventral Hernia Working Group types 3 and 4 were prospectively
enrolled and subsequently treated with direct supported repairs with condensed fenestrated polytetra-
fluoroethylene mesh. The primary outcome was hernia occurrence at 1 year after surgery. Secondary
outcomes included surgical site infection, surgical site occurrence, medical complications, pain, and
other patient-reported outcomes.
RESULTS: There were no immediate postoperative infections and one minor postoperative hema-
toma treated in the office. One patient required delayed mesh removal 9 months after placement. Impor-
tantly, the mesh removal procedure was straightforward because of the material properties of the mesh.
Of the 9 patients still with mesh, there were no hernia recurrences at the repair site with one full year of
follow-up.
CONCLUSION: Contaminated and clean–contaminated abdominal wall defects can be effectively
and durably treated with condensed polytetrafluoroethylene mesh.
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2 The American Journal of Surgery, Vol 211, No 1, January 2016Optimal management of the patient with a contaminated
or clean–contaminated abdominal wall defect remains hotly
debated. Contamination can be at the level of the abdom-
inal wall with wounds or areas of drainage, or may be
because of bowel manipulation with a suture line. The
ability to close surface wounds preoperatively is an
excellent strategy for many, but it is not always feasible
and often requires a second operative procedure.1,2 Patients
with hernias who require a gastrointestinal procedure need
strategies to contain the viscera to prevent evisceration after
the hernia sac is opened and the bowel work completed.
The ideal operation for a contaminated or potentially
contaminated ventral hernia would be reproducible, single
stage, and durable. Simple suture approximation of the
abdominal wall ventral hernia defect is associated with
high failure rates.3 Bioprosthetic mesh reinforcement of
the hernia suture line, originally thought to have great
promise, has shown limitations with long-term follow-up
in the single-stage closure of contaminated defects.4,5
Cautions to the use of prosthetic mesh were raised by the
Ventral Hernia Working Group (VHWG) in Grades 3
(potentially contaminated) and 4 (contaminated) repairs
because of the presumed difficulty in reoperation if the
mesh became contaminated.6
Condensed fenestrated polytetrafluoroethylene (cPTFE;
MotifMESH; Proxy Biomedical, Galway, Ireland) has
several physical characteristics and properties that poten-
tially render it a useful tool in these challenging clinical
scenarios. Considering the suboptimal alternative current
treatment strategies, a prospective study was designed to
determine the clinical outcomes of 10 patients treated for
contaminated or clean–contaminated ventral hernias. To
our knowledge, this is the first clinical study performed
using this 510K US Food and Drug Administration-
approved cPTFE mesh submitted for publication.Patients and Methods
A single surgeon prospective case series for treatment of
10 patients with VHWG Grade 3 and 4 hernias received
IRB approval and commenced in 2011. The study complies
with the Declaration of Helsinki ethical principles for
medical research involving human subjects. Enrollment
criteria included a ventral hernia with an overlying wound
that could not be easily closed with a preoperative surgical
procedure, or a ventral hernia with a planned entry into the
gastrointestinal tract. Exclusion criteria included age under
18 or over 80 years, inability to provide written consent in
English, pregnancy, American Society of Anesthesiologists
Physical Status Class IV, inguinal hernias, body mass index
(BMI) greater than 40, and patients with grossly infected
wounds with necrosis. Patients were enrolled from a busy
plastic surgery clinic without outside recruitment. The
primary investigator obtained informed consent for each
patient. Preoperative data collected included demographics,
prior surgical history, and prior medical history. Apreoperative abdominal and pelvic noncontrast CT scan
was obtained for characterization of the hernia. Intra-
operative data collected included surgical technique for
closure, assessment of local tissue quality, need for
components releases, and ability to achieve fascial closure.
Postoperative data were collected at standard points for 1
year. Five postoperative visits were scheduled for each
patient, including the first and second postoperative weeks,
as well as 1, 3, and 12 months after surgery. Primary
outcome variables included the presence of surgical site
infection (SSI) as defined by the National Surgical Quality
Improvement Project within 30 days, surgical site occur-
rence (SSO) including seroma, wound dehiscence, enter-
ocutaneous fistula as defined by the VHWG, and the
development of a hernia. A postoperative computed to-
mography (CT) was obtained in all patients at the time of
their final follow-up. Medical complications in the post-
operative period were recorded. In addition, assessments of
pain, fatigue, movement, and overall well-being were
assessed on a 10-point scale preoperatively and at all
postoperative time points.Surgical procedure
While the patients entered this study with differing
diagnoses, the surgical principles used for treatment were
the same. No specific regimen for preoperative preparation
was undertaken except for mechanical bowel prep the day
before surgery consisting of magnesium citrate and 10 mg
bisacodyl with clear liquids only. The patients were all
widely surgically prepped with chlorhexidine gluconate
without special drapes or skin covers. In the presence of
an open wound, povodine–iodine was used for a preparatory
skin antiseptic. For patients undergoing bowel surgery, the
procedures commenced with general surgery, and turned
over to plastic surgery for their closure. For the remaining
patients, the procedures commenced with an en bloc
excision of inflamed and contaminated tissue to reduce
bioburden.7 Skin flap elevation was minimized to preserve
skin perforators, as this has been shown to decrease local
wound complications.8 The skin was elevated off of the fas-
cia approximately 4 cm to allow placement of anchoring su-
tures. When present, bowel suture lines were covered with
vascularized tissue, such as the omentum, and located
away from the mesh. The total amount of mesh used for
the case was minimized to limit the total amount of foreign
material present, decrease soft tissue elevation necessary for
placement, and avoid mesh wrinkling.9 A 7.5 cmwidth piece
of cPTFE mesh was utilized for a direct supported repair
with either intra-abdominal or retrorectus mesh placement.10
Interrupted transabdominal wall ‘‘U’’ shaped 0-
polypropylene sutures spaced approximately 2 cm from
each other and 4 cm from the fascial midline were used to
anchor the mesh in place. This creates 4 cm of underlay of
the mesh and allows for approximation of the fascial midline
using interrupted figure of eight 0-polypropylene sutures.
J.E. Cheesborough et al. cPTFE use in non-sterile hernia repairs 3Eight patients underwent intra-abdominal mesh place-
ment (with mobilization of preperitoneal fat or omentum to
provide a layer of vascularized tissue between the mesh and
bowel) and 2 patients with midline defects had retrorectus
mesh placement. In all but one case, a direct supported
repair with primary fascial closure was achieved. One
patient had a bridged repair of a 22 cm defect ultimately
requiring bilateral components releases and 8 cm of
spanning mesh between the rectus muscles.
Four patients underwent components separation, with
separate lateral subcostal incisions performed to maintain
skin vascularity (Fig. 1A–D). Eight of the 10 cases were
directly in the midline, one chevron incision hernia
involved both vertical and transverse components, and the
last involved reconstruction of a transverse rectus abdomi-
nis myocutaneous flap defect with absent right rectus
muscle.
The soft tissues were kept moist during the procedure
with antibiotic irrigation (80 mg gentamicin per liter).
Excess skin at the incision site was removed sharply to
decrease surgical dead space, to remove potentially
ischemic skin flaps, and as a final means to cleanse the
incision of possible implanted bacteria at the time of
closure. Skin was quilted down to the abdominal wall
where technically possible to decrease surgical dead space.Figure 1 (A–D) A 37-year-old male with a 12-cm incisional hernia fo
He was treated with bilateral components releases, intra-abdominal cPT
wounds.The skin was closed with absorbable monofilament deep
dermal sutures and staples or running intracuticular per-
manent monofilament sutures depending on patient prefer-
ence. Seven millimeter Jackson–Pratt clot stop drains were
placed in the subcutaneous plane for all patients. Two
drains were used for single incision repairs and 3 drains
were utilized if lateral components release incisions were
required. Most of the drains were removed before the
patient left the hospital.
No nasogastric tubes were used postoperatively, and
parenteral narcotics were used for analgesia. Intravenous
antibiotics were used for a mean of 2.6 days and a median
of 2 days for the group. Patients did receive postoperative
anticoagulation with enoxaparin. Average hospital stay was
8 days.Case 1. A 76-year-old male has a 7-cm wide midline
ventral hernia, loss of domain, and 4 prior attempts at
repair. He is found on physical examination to have a right
colon cancer palpable within the hernia sac. A right
hemicolectomy is performed through a midline incision.
The hernia is closed with components separation releases,
perforator preservation, and a direct supported repair with
cPTFE mesh. He had an uneventful postoperative recoveryllowing a gastric pull-up procedure and open abdominal wounds.
FE hernia repair, and excision of the thinned skin and abdominal
Figure 2 (A) Preoperative photo of a 76 year old with a massive hernia, loss of domain, and right colon cancer. (B) Preoperative CT scan
of hernia with loss of domain. (C) Intraoperative photo after right colectomy (D) Intra-abdominal cPTFE (MotifMESH) partially inset with
transrectus abdominal sutures placed. (E) Direct supported repair. Note the minimized skin elevation with preservation of soft tissue and
skin perforators to maintain skin vascularity. (F) Postoperative photo 1 year after the procedure. (G) Postoperative CT scan 1 year after the
procedure. The cPTFE mesh can be seen as a faint white line behind the rectus muscles.
4 The American Journal of Surgery, Vol 211, No 1, January 2016with no evidence of hernia recurrence on his CT scan at 1
year or at follow-up 20 months after surgery (Fig. 2A–G).
Case 2. A 39-year-old female with Crohn’s disease had a
bowel resection and diverting ileostomy, complicated by
the development of a 6-cm midline ventral hernia. Her
ileostomy takedown was performed through a midline
incision, and a direct supported retrorectus repair using
cPTFE was performed. She had an uneventful postoperative
recovery with no evidence of recurrent hernia formation at
1 year on CT scan and physical examination (Fig. 3A,B).
Case 3. A 56-year-old female with a history of breast
cancer and prior transverse rectus abdominis myocutaneous
flap breast reconstruction developed an infection of the
polypropylene mesh onlay used to close defect caused by
harvest of the entire right rectus muscle. The patient was
taken to the operating room in 2008 for removal of the
polypropylene mesh, and a suture closure of the abdominal
wall defect was performed. Cultures demonstrated Staphy-
lococcus aureus resistant to oxacillin but sensitive to Bac-
trim and clindamycin. The patient then developed an
8.5 cm hernia at this location along with renewed drainage.
She was taken to the operating room for removal of any
additional polypropylene mesh and repair of the fascial
defect with intra-abdominal cPTFE mesh. She had an un-
eventful course until 9 months later when she developed
a small sinus tract and an apparent seroma around the un-
incorporated mesh seen on CT scan (Fig. 4A). She was
taken to the operating room for removal of the cPTFEmesh. The wrinkled unincorporated cPTFE was removed
easily, and a ‘‘fibrous rind’’ was present at the base of the
wound to contain the bowel (Fig. 4B,C). A piece of unin-
corporated polypropylene mesh thought to be from the
original procedure was discovered and removed. Scar was
reapproximated superficial to the fibrous rind with sutures
to reinforce the abdominal wall and has remained intact
with 2 years of follow-up. Wound cultures demonstrated
the same bacterial profile as the original cultures taken.Results
A total of 10 patients participated in this study (Table 1).
Ages ranged from 37 to 76 years. Four patients were female
and 6 patients were male. The majority of the patients had
premorbid conditions including prior visceral transplantation
(2), prior malignancy, Crohn’s disease, smoking (4), and dia-
betes. Average BMI was 28 with 4 patients having a BMI
greater than 30. The reasons for the noted contamination
included bowel repair (5), exposed mesh (3), or skin wounds
and local contamination (2). Five patients had a repair of a
recurrent ventral hernia. For the 8 patients with linea alba her-
nias, the average transverse separation of themedial aspect of
the rectus muscles was 10.7 cm. Nine of the 10 patients were
followed for the full year after the procedure. One patient was
in jail at the time of his final scheduled clinic visit.
Mean total surgery time for these cases was 199 minutes:
227minutes for the caseswithgeneral surgery and2attendings,
Figure 3 (A) A 39-year-old female with Crohn’s disease, diverting ileostomy, and midline ventral hernia. (B) One-year postoperative
photo after cPTFE direct supported repair.
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was required. Mean length of stay was 86 3.8 days.
There were no SSIs within the 30-day period after
surgery. There was 1 SSO (10%) of a small hematoma
located in the lateral incision for performance of a
components release. This hematoma was drained in the
office. Patients had several early postoperative medical
complications including an superior mesenteric vein throm-
bosis and pulmonary embolism, chronic renal failure from
antibiotics given at an outside hospital (resolved), and a 2-
week postoperative oxygen requirement for Case presenta-
tion number 1 of a massive hernia present for over 20 years
with loss of domain. Complications for these patients over
the year of follow-up included a late mesh removal as will
be described, a transient bowel obstruction at 4 months that
cleared overnight with bowel rest, and an inguinal hernia
not contiguous with the cPTFE hernia repair.
The 9 patients still with mesh were followed from 12 to
28 months (mean 18 months). All 8 patients who received
1 year follow-up CT scans demonstrated well-placed flat
mesh, without any fluid collections or hernias. The incar-
cerated patient was examined by his local physician and did
not have any drainage or hernia at 1 year. The final patientFigure 4 (A) CT scan 7 months after placement of cPTFE demonstrat
removal of infected cPTFE in a prior transverse rectus abdominis myocu
on the deep aspect of the cavity to contain the viscera. (C) The explanhad recurrent drainage from her midline suture line at
7 months. This drainage was initially treated with oral
antibiotics. However, the failure of this drainage to resolve
led to an early CT scan that demonstrated wrinkling of the
mesh and perimesh fluid (Fig. 4A). At the time of her cPTFE
mesh placement, the senior surgeon was unable to perform
an en bloc resection of her contaminated polypropylene
mesh, and instead had piecemeal removal. The salvage sur-
gery to remove the infected cPTFE mesh was notable for its
ease. As hypothesized by its PTFE material composition, a
fibrous rind encapsulated the infected mesh. The mesh was
straightforward to remove by simply following the draining
skin sinus down to the mesh and widely opening the tissues
superficial to it. Prolene sutures still holding the mesh were
cut, and the mesh came out with blunt dissection (Fig. 4B,C).
Individual bowel loops were not noted, as they were held in
place by the fibrous rind. The cavity wall surface was gently
debrided, a drain was placed, and the fascia and skin was
closed. While a hernia in this patient is expected to develop,
at the patient’s last office follow-up the rind had not yet soft-
ened to demonstrate a recurrent hernia.
Patient-reported outcomes of fatigue, movement, and
overall sense of well-being improved in these patients ining wrinkling and perimesh fluid. (B) Intraoperative photograph of
taneous flap donor site. The mesh is wrinkled. A fibrous rind exists
ted MotifMESH. Note the lack of tissue ingrowth.
Table 1 Patient and procedure characteristics
Patient
Age
(years)
Male
sex
Hernia
width
(cm) Preoperative notes
Prior
infection Procedure
Length
of stay
(days)
SSIs
at 30
days
Postoperative complication(s)
including SSOs up to 1 year
1 56 No 8.5 Transverse rectus abdominis
myocutaneous flap breast
reconstruction with polypropylene
mesh to repair the abdominal
defect became infected years
after the procedure. A large
piece of mesh was removed
but retained mesh segments
led to persistent drainage
and infection
Yes Through the transverse
incision of the TRAM flap,
the infected polypropylene
mesh was removed with
incisional hernia repair
with intra-abdominal
MotifMESH
5 0 9 months after the procedure,
a small sinus tract
developed.
The MotifMESH was removed
and at that time, a small
portion of retained
polypropylene mesh was
discovered. The fascial
defect was closed primarily
2 76 Yes 15 20- to 30-year history of massive
midline hernia despite prior
prosthetic repair attempts.
New diagnosis of colon cancer
No Right hemicolectomy, bilateral
components releases,
incisional hernia repair with
intra-abdominal MotifMESH
7 0 Right upper lobe PE on POD 5,
treated with supplemental
oxygen
3 59 Yes 22 Prior open abdomen treated with
split thickness skin grafting.
Developed an enterocutaneous
fistula. ECF taken down and
hernia repaired with internal
and external components releases
and biologic mesh bridging repair
Yes Bilateral components releases,
repair of enterotomy, spanning
MotifMESH hernia repair
6 0 None
4 54 Yes 6.5 Chevron incision for orthotopic liver
transplant developed a hernia
which was repaired by the
transplant team with polyester
coated mesh. This mesh became
infected, started draining, and the
patient developed a large hernia
Yes Removal of infected mesh, repair
of the Chevron incisional hernia
with intra-abdominal MotifMESH
5 0 None
5 51 Yes 7.5 Kidney transplant patient, prior
ventral incisional hernia repair
with mesh complicated by
infection of the mesh and
recurrent hernias
Yes Removal of infected mesh,
retrorectus MotifMESH hernia
repair
6 0 None
6 29 Yes 5.7 Diverticulitis s/p laparoscopic
sigmoidectomy complicated by
open abdominal wound, bowel
stricture, umbilical hernia
Yes Exploratory laparotomy, small
bowel resection with
anastomosis, excision of
cutaneous wound, ventral
hernia repair with
intra-abdominal MotifMESH
7 0 None
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7 63 No 8 Metastatic leiomyosarcoma resection
complicated by small bowel
obstruction requiring exploratory
laparotomy and small bowel
resection. This was complicated
by a wound infection
No Exploratory laparotomy, small
bowel resection with
anastomosis, cholecystectomy,
intra-abdominal MotifMESH
hernia repair
16 0 SMV thrombosis on POD 10
requiring IV heparin
treatment
8 39 No 6.2 Crohn’s disease with ileostomy and
incisional hernia
No Ileostomy take down, retrorectus
MotifMESH ventral hernia repair
10 0 None
9 51 No 7.3 Prior distal pancreatectomy for
neuroendocrine tumor with
postoperative diabetes and a
recurrent incisional hernia
complicated by an infected
seroma surrounding the mesh
Yes Abdominoplasty (transverse skin
incision for access), removal of
previously placed mesh,
bilateral components releases,
intra-abdominal MotifMESH
hernia repair
6 0 None
10 37 Yes 12 Prior Ivor–Lewis esphagectomy
complicated by an incisional
hernia and open skin wounds
of the abdomen
Yes Excision of abdominal
skin wounds, bilateral
components releases,
intra-abdominal MotifMESH
hernia repair
6 0
Mean 51.5 9.9 7.4
Median 52.5 7.8 6
Total 6/10 7/10 0 SSIs 2 SSOs
ECM 5 enterocutaneous fistula; IV 5 intravenous; PE 5 pulmonary embolism; POD 5 post operative day; SMV 5 superior mesenteric vein; SSI 5 surgical site infection; SSO 5 surgical site occurrence;
TRAM 5 transverse rectus abdominis myocutaneous.
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Figure 5 Patient-reported outcomes for fatigue, movement, and
overall sense of well-being before and 1 year after surgery on a
10-point scale.
8 The American Journal of Surgery, Vol 211, No 1, January 2016comparison with their own preoperative assessment on a
10-point grading scale (Fig. 5). A 10-point visual analog
scale for pain demonstrated a steady decline in patient-
reported pain over the year after surgery (Fig. 6).Comments
All strategies for treatment of the patient with a VHWG
Class 3 or 4 ventral hernia have significant potential
drawbacks and complication rates. Closure of the wound
preoperatively is a straightforward approach, but it often
requires a second procedure, delays final resolution of the
clinical problem, and is not always possible when there is
exposed mesh. Patients in need of bowel surgery and with a
pre-existing hernia can undergo an abdominal wall suture
closure either with or without components release, but the
long-term hernia rate will be at least 1 in 4 and possibly
much higher.11 Direct repairs supported with bioprosthetic
mesh held great promise for a solution to this problem, as
the bioprosthetics were touted to be resistant to contamina-
tion through the process of incorporation.6 The VHWG
specifically recommended the use of bioprosthetics in these
cases, as the risk of SSO with permanent meshes was
thought to be prohibitive. However, bioprosthetic utilityFigure 6 Patient-reported outcome for pain using a 10-point
visual analog scale vs time from the procedure.has not achieved its initial promise. The Repair of Infected
or Contaminated Incisional Hernias study of single-stage
treatment of clean–contaminated and contaminated cases
with a non–cross-linked porcine dermis had a 66% SSO
rate, a 30% SSI rate, and a 28% hernia rate at 2-year
follow-up.12 This small series compares favorably to a
recently published multicenter series by Carbonell et al4
on the use of lightweight polypropylene in similar cases.
Operative times were shorter (199 vs 247 minutes), length
of stay similar (8.0 6 3.8 vs 8.7 6 8.1 days), and cPTFE
had a lower 30-day SSI (0% vs 11%). The surgical tech-
niques of the 2 series were quite different, with this study
performing anterior components releases when necessary
and often placing the mesh intra-abdominally, while the
comparison study predominantly performed posterior re-
leases to achieve soft tissue coverage of a retrorectus placed
mesh. Most importantly, both trials demonstrated the ability
to place mesh in these clinical situations with low rates of
removal. In this cPTFE trial, one mesh was removed (10%),
while in the Carbonell series there was a mesh removal rate
of 4%, and a hernia rate of 7%.3 The difficulty in removing
the mesh in the Carbonell paper was not addressed.
Condensed PTFE placed into potentially contaminated
or contaminated fields in this small series of patients
demonstrated low complication rates. SSI within 30 days
was 0%, while SSO for the 1-year study period was 20%
with 1 office treated hematoma and 1 delayed mesh
infection requiring removal. While an aspect of this
generally favorable study may be patient selection, both
the mesh and the manner of its implantation may also be
important. MotifMESH has a particular design with pores
2,400 microns in size. Pores greater than 1,000 microns are
thought to avoid bridging scar13 and to promote incorpora-
tion rather than encapsulation.14 Tissue incorporation asso-
ciated with macroporosity is important in the prevention of
infection and the clearance of bacteria.15 Condensed PTFE
is a hydrophobic material, with this material property
thought to be important in the avoidance of a bacterial bio-
film.16 In comparison with expanded PTFE (ePTFE),
cPTFE demonstrates significantly less bacterial adher-
ence.15,16 Unlike the more common ePTFE, cPTFE has a
smooth surface and does not have any microporous
‘‘pits.’’ These pits increase the surface area of ePTFE,
and perhaps potentiate the ability of bacteria to adhere
and ‘‘hide’’ from adjacent macrophages.17 Its overall per-
formance was judged favorably in an independent evalua-
tion of infection, shrinkage, and bowel adherence in
comparison with other synthetic and bioprosthetic meshes
when placed into a contaminated rat abdominal wall.14
Condensed PTFE is thin (.15 mm), soft, and compact
without the weaving of fibers of standard meshes. This de-
creases its surface area in comparison with woven multifil-
ament meshes and with ePTFE.18 The total amount of
foreign material surface area may have a direct correlation
to late infection. One property shared by cPTFE and ePTFE
is the minimization of significant bowel adhesions as
demonstrated in rat and porcine models.19–21 This is
J.E. Cheesborough et al. cPTFE use in non-sterile hernia repairs 9important for instances when the cPTFE mesh is placed
intra-abdominally and possibly adjacent to the abdominal
viscera. The positive results of this study are all the more
important, considering the issue that the responses to
foreign materials in humans may be quite different to the
tissue reactions to biomaterials in other species.22
Technical aspects of performance of the procedure may
also have contributed to the overall success of abdominal
wall reconstruction in these clean–contaminated and
contaminated cases. Maintenance of skin vascularity is
emphasized, as this has been shown to decrease wound
complications. No specific patient preparation is required,
such as glycemic control or antibiotic baths, as the focus is
instead on removing unhealthy tissue such as scar or excess
abdominal skin that would lead to potential complications.
The total amount of cPTFE mesh is limited intentionally
(only a 7.5 cm wide mesh), as it is logical that a greater
surface area of foreign material will require a greater
healing effort of the body to incorporate, require larger
tissue flaps for placement, and provide more places for
bacterial adherence. The outer edges of a narrow mesh
wrinkle less than the outer edges of a wide mesh placed
snuggly against the curved contours of the abdominal wall.
Mesh wrinkles may predispose the patient to late bowel
erosions and skin extrusions. Only enough mesh is placed
to effectively distribute forces across the repair site and to
decrease suture pull-through.23 Finally, it is a well-
described phenomenon that rigidly fixed implants in well-
vascularized tissue beds do not become infected.24 The
‘‘quilting’’ of the narrow mesh to the undersurface of the
abdominal wall with up to 40 transabdominal wall sutures
surgically fixes the mesh in a manner distinct from other
techniques of mesh fixation.
Analysis of the 1 surgical failure is as important as the
appreciation of the 9 successfully treated patients. The 1
patient who required her mesh removed demonstrated
important properties of MotifMESH that facilitated the
diagnosis and treatment of the infection. This one patient
was the only one to have delayed drainage, and the
only patient to have wrinkled mesh on follow-up CT scan
(Fig. 4A). The ability to ‘‘see’’ the mesh on CT scan because
of its composition facilitated the diagnosis that the mesh was
not incorporated unlike the other patients with flat meshes
seen on CT. The unusual postoperative appearance of the
mesh on imaging along with the drainage led to the surgical
exploration, revealing the wrinkled mesh encapsulated by an
outer scar or rind (Fig. 4A–C). Contractile properties of the
scar tissue caused the mesh to buckle or wrinkle. The impor-
tance of the retained polypropylene mesh as the likely source
for infection cannot be minimized. The infection likely
contributed to the poor integration of the mesh. The mesh
removal procedure lasted 80 minutes and did not require
any bowel dissection. When ePTFE becomes infected, the
tissue response is to create a fibrous rind.19 The fibrous
rind developed with this case of cPTFE as well. The fibrous
rind has enough strength to contain the bowel and it obviates
the need to reconstruct the abdominal wall in the inflamedfield. In senior author’s opinion, a central advantage of the
use of MotifMESH mesh in clean–contaminated and
contaminated cases is the ease of the salvage procedure of
mesh removal if necessary. This one case was far different
from the surgical removal of infected polypropylene meshes
performed by the senior author that mandated bowel dissec-
tions and a means to contain the viscera. It is interesting that
in the larger series of Carbonell where 4 meshes were
removed surgically, there was no mention of the difficulty
involved in their removal.12
Patients overall reported decreased pain and fatigue after
these procedures. This probably relates to the reduction of
total body inflammation in some patients, and to the
treatment of their hernias in others. Improvement in
movement and overall sense of well-being was also noted.
Restoration of more normal abdominal wall compliance
may explain the improved pain and movement scores.
These 4 issues undoubtedly trend together and reflect
successful abdominal wall reconstruction.Conclusions
In summary, this small prospective series of cPTFE
ventral hernia repairs provides surgeons with an additional
method for treating patients with clean–contaminated and
contaminated ventral hernias. The properties of the mesh
facilitated the handling of these challenging cases.References
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